Ocuphire Pharma
zeta characteristics well balanced across arms study eye study eye | Ocuphire Pharma
Company
Deck Type
Deck date
May 2023
Slide
14 of 27
Related slides by other companies
Oculis
Results
May 2023
reduction in achieved with sustained to week as assessed by optical coherence tomography | Oculis
Bausch+Lomb
Investor Conference
January 2023
date june | Bausch+Lomb
Theravance Biopharma
Investor Conference
November 2022
study disposition | Theravance Biopharma
Theravance Biopharma
Investor Conference
November 2022
study disposition | Theravance Biopharma
Other recent decks by Ocuphire Pharma
See all presentations (10 decks)
Investor Presentation
November 2023
Investor Presentation
August 2023
Results
January 2023
Results
October 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io